Last reviewed: May 1, 2026
Listen now
Episode breakdown
Key takeaways
- Medical device risk assessments often fail due to a lack of understanding of the actual user environment where the device will operate.
- Effective risk identification and mitigation strategies for medical devices require direct observation and understanding of the clinical setting.
- Ignoring the user environment in early development can lead to minor issues escalating into significant problems and costs later on.
- Manufacturers commonly misunderstand that CE marking signifies an audit pass, not a guarantee of product quality, and that FDA clearance is not equivalent to FDA approval.
- Cybersecurity risk assessments in medical devices suffer from the same neglect of the user environment as general device risk assessments.
- Investing in thorough risk assessments and understanding the user environment from the outset is crucial for preventing costly problems and ensuring device safety and efficacy.
Medical device risk assessments are failing patients, not because the process is too hard, but because nobody doing the assessment has ever been in the room where the device actually gets used.
MedTech quality and regulatory leader Stephen Smith describes sitting in a risk session for a device going into an intensive care unit. Twelve people in the room, and not one had ever set foot in an ICU. If you have never been in the environment your device will operate in, risk identification becomes guesswork, mitigations get written for problems that are not the actual problems, and the device goes to market with gaps that stay hidden until something goes wrong.
This episode covers why the user environment is the most consistently ignored variable in medical device development, and how that same gap shows up in cybersecurity risk assessments.
Also discussed: the $5,000 problem that gets rationalized today has a way of becoming the $500,000 crisis that cannot be ignored tomorrow, and what this argument actually looks like in practice.
Stephen also explains why CE marking proves you passed an audit and why FDA clearance does not mean the FDA approved your device.
Worth listening to if you are focused on MedTech quality, regulatory, or cybersecurity.
Frequently asked questions
Bring this work to your device
Need help with fda premarket cybersecurity?
Blue Goat Cyber delivers fda premarket cybersecurity services for medical device manufacturers - from threat modeling to FDA-ready reports.
FDA Premarket Cybersecurity ServicesMore on FDA Premarket Cybersecurity
Keep listening
-
Episode 69
Science Before Hype in MedTech Investing with Varun Turlapati of Chaanakya Capital
With Varun Turlapati
-
Episode 67
De-Risking Product Decisions in MedTech Startups with Brent Lavin of Ironwood MedTech Partners
With Brent Lavin
-
Episode 65
Why Clinical Trials Are the Most Expensive Capital Outlay for Startups with Rob Bedford, CEO of Franklyn Health
With Rob Bedford
-
Episode 64
Traceability Requirements and Documentation Audit Trails with Dr. Basant Bajpai, CEO of Compliance MedQRA
With Dr. Basant Bajpai